Trump Promises AstraZeneca to Lower Drug Prices

In a landmark announcement that underscores the administration’s commitment to healthcare affordability, U.S. President Donald Trump declared that AstraZeneca would reduce drug prices in America. This decision follows closely on Pfizer’s heels, where similar commitments were made to curb escalating pharmaceutical costs. The move is seen as a significant stride towards alleviating the financial burden on American consumers.

At a press briefing held at the White House, President Trump highlighted this development as part of his administration’s broader agenda to tackle high drug prices—a top priority during his tenure. He pointed out that Americans are charged some of the highest prices for medications globally. The revelation came shortly after Pfizer announced plans to lower their drug costs in the U.S., marking a continued effort to negotiate with major pharmaceutical companies.

Trump emphasized, “Britain’s largest pharmaceutical company, AstraZeneca, has pledged to offer significant discounts on its prescription medication catalog to American consumers. This is indeed heartening.” He stressed that these reductions would make numerous medications more affordable for citizens, addressing long-standing concerns about drug affordability.

In prior discussions with Pfizer, the administration reached an agreement that set a precedent for lower pharmaceutical prices in the U.S., which Trump reiterated during this announcement. He drew attention to the stark contrast between American drug pricing and the more competitive rates offered in other countries, asserting that such discrepancies necessitated negotiations with leading manufacturers to drive down costs.

Through these efforts, President Trump’s administration aims to sustain momentum in reducing pharmaceutical expenses for Americans, striving to ensure that healthcare remains accessible and affordable. This announcement is another step towards fulfilling promises of reform within the U.S. drug market, aligning with ongoing strategies to negotiate more favorable terms for consumers across the nation.

Original Article Source: Trump Promises AstraZeneca to Lower Drug Prices - Haberler